EP3377085A4 - Peptides and methods of treating endometriosis using the same - Google Patents
Peptides and methods of treating endometriosis using the same Download PDFInfo
- Publication number
- EP3377085A4 EP3377085A4 EP16862963.2A EP16862963A EP3377085A4 EP 3377085 A4 EP3377085 A4 EP 3377085A4 EP 16862963 A EP16862963 A EP 16862963A EP 3377085 A4 EP3377085 A4 EP 3377085A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- peptides
- methods
- same
- treating endometriosis
- endometriosis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 201000009273 Endometriosis Diseases 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/202—IL-3
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/36—Gynecology or obstetrics
- G01N2800/364—Endometriosis, i.e. non-malignant disorder in which functioning endometrial tissue is present outside the uterine cavity
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Urology & Nephrology (AREA)
- Pharmacology & Pharmacy (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Physics & Mathematics (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2015/058877 WO2016073513A1 (en) | 2014-11-03 | 2015-11-03 | Pif binding as a marker for immune dysregulation |
| US201662317628P | 2016-04-03 | 2016-04-03 | |
| PCT/US2016/060319 WO2017079430A1 (en) | 2015-11-03 | 2016-11-03 | Peptides and methods of treating endometriosis using the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP3377085A1 EP3377085A1 (en) | 2018-09-26 |
| EP3377085A4 true EP3377085A4 (en) | 2019-07-17 |
Family
ID=58663080
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP16862963.2A Withdrawn EP3377085A4 (en) | 2015-11-03 | 2016-11-03 | Peptides and methods of treating endometriosis using the same |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP3377085A4 (en) |
| AU (1) | AU2016349358B2 (en) |
| CA (1) | CA3004055A1 (en) |
| IL (1) | IL259096A (en) |
| WO (1) | WO2017079430A1 (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3341739A4 (en) | 2015-08-28 | 2019-07-10 | BioIncept LLC | Mutant peptides and methods of treating subjects using the same |
| AU2016317574A1 (en) | 2015-08-28 | 2018-03-29 | Bioincept, Llc | Compositions and methods for the treatment of neurodamage |
| US20200246424A1 (en) * | 2017-07-17 | 2020-08-06 | Bioincept, Llc | Peptides and methods of transplantation and restorative organ function |
| WO2020106995A1 (en) * | 2018-11-21 | 2020-05-28 | Endomet Biosciences, Inc. | Compositions and methods for treating endometriosis |
| CN113845582B (en) * | 2021-10-15 | 2022-05-27 | 南京市妇幼保健院 | Application of endogenous polypeptide in preparation of targeted drug for preventing or treating endometrial cancer |
| EP4248985A1 (en) * | 2022-03-25 | 2023-09-27 | Consejo Superior de Investigaciones Científicas (CSIC) | Peptides for the treatment of retinitis pigmentosa |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014201118A2 (en) * | 2013-06-11 | 2014-12-18 | Sanford-Burnham Medical Research Institute | Compositions and methods for targeted endometriosis treatment |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5646003A (en) * | 1994-03-23 | 1997-07-08 | Barnea; Eytan R. | Preimplantation factor |
| AU4233500A (en) * | 1999-04-16 | 2000-11-02 | Bioincept, Inc. | Identification of a serum marker for endometriosis |
| US7723290B2 (en) * | 2004-10-22 | 2010-05-25 | Bioincept, Llc | Compositions and methods for modulating the immune system |
| US7723289B2 (en) * | 2003-10-22 | 2010-05-25 | Bioincept, Llc | PIF tetrapeptides |
| EP2970496B1 (en) * | 2013-03-12 | 2018-07-18 | Institute of Arthritis Research LLC | Immunologically active polypeptide |
| EP3215847A4 (en) * | 2014-11-03 | 2018-02-14 | Bioincept LLC | Pif binding as a marker for immune dysregulation |
-
2016
- 2016-11-03 EP EP16862963.2A patent/EP3377085A4/en not_active Withdrawn
- 2016-11-03 AU AU2016349358A patent/AU2016349358B2/en not_active Ceased
- 2016-11-03 CA CA3004055A patent/CA3004055A1/en not_active Abandoned
- 2016-11-03 WO PCT/US2016/060319 patent/WO2017079430A1/en not_active Ceased
-
2018
- 2018-05-02 IL IL259096A patent/IL259096A/en unknown
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014201118A2 (en) * | 2013-06-11 | 2014-12-18 | Sanford-Burnham Medical Research Institute | Compositions and methods for targeted endometriosis treatment |
Non-Patent Citations (2)
| Title |
|---|
| MARCO SBRACIA ET AL: "PreImplantation Factor in endometriosis: A potential role in inducing immune privilege for ectopic endometrium", PLOS ONE, vol. 12, no. 9, 13 September 2017 (2017-09-13), pages e0184399, XP055439008, DOI: 10.1371/journal.pone.0184399 * |
| See also references of WO2017079430A1 * |
Also Published As
| Publication number | Publication date |
|---|---|
| EP3377085A1 (en) | 2018-09-26 |
| AU2016349358B2 (en) | 2019-12-05 |
| IL259096A (en) | 2018-06-28 |
| AU2016349358A1 (en) | 2018-06-14 |
| WO2017079430A1 (en) | 2017-05-11 |
| CA3004055A1 (en) | 2017-05-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL276515B2 (en) | Pd-l1-specific antibodies and methods of using the same | |
| EP3270917A4 (en) | Compounds and methods for the enhanced degradation of targeted proteins | |
| EP3157471A4 (en) | Exoskeleton and method of using the same | |
| ZA202104969B (en) | Compositions comprising 15-hepe and methods of using the same | |
| EP3145523A4 (en) | Ras inhibitory peptides and uses thereof | |
| EP3285805A4 (en) | Therapeutic antibodies and uses thereof | |
| EP3394098A4 (en) | Anti-myostatin antibodies and methods of use | |
| EP3274472A4 (en) | Antimicrobial peptides and methods of use thereof | |
| EP3215172A4 (en) | Modifications and uses of conotoxin peptides | |
| IL259096A (en) | Peptides and methods of treating endometriosis using the same | |
| EP3288379A4 (en) | Peptide compositions and methods of use | |
| EP3245272A4 (en) | Novel proppant and methods of using the same | |
| EP3313427A4 (en) | Therapeutic peptides and methods of use thereof | |
| EP3220908A4 (en) | Compositions and methods for treating endometriosis | |
| EP3334730A4 (en) | Pyrrolomycins and methods of using the same | |
| ZA201901942B (en) | Nnif and nnif-related peptides and related methods | |
| EP3270985A4 (en) | Polypeptide compositions and methods of using the same | |
| EP3341739A4 (en) | Mutant peptides and methods of treating subjects using the same | |
| EP3399990A4 (en) | Therapeutic compositions including peptides and uses thereof | |
| EP3178838A4 (en) | Koc1-derived peptide and vaccine including same | |
| EP3325499A4 (en) | Novel peptide and use thereof | |
| EP3209697A4 (en) | Fn14-binding proteins and uses thereof | |
| EP3241022A4 (en) | Methods for protein and peptide reduction | |
| EP3166406A4 (en) | Cytokine-chitosan bioconjugates and methods of using the same | |
| SG11201610918RA (en) | Peptides and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
| 17P | Request for examination filed |
Effective date: 20180604 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| AX | Request for extension of the european patent |
Extension state: BA ME |
|
| DAV | Request for validation of the european patent (deleted) | ||
| DAX | Request for extension of the european patent (deleted) | ||
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R079 Free format text: PREVIOUS MAIN CLASS: A61K0038000000 Ipc: G01N0033567000 |
|
| A4 | Supplementary search report drawn up and despatched |
Effective date: 20190614 |
|
| RIC1 | Information provided on ipc code assigned before grant |
Ipc: G01N 33/68 20060101ALI20190607BHEP Ipc: C07K 7/08 20060101ALI20190607BHEP Ipc: G01N 33/564 20060101ALI20190607BHEP Ipc: G01N 33/567 20060101AFI20190607BHEP |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
| 17Q | First examination report despatched |
Effective date: 20221103 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20230314 |